Browse > Article

The Role of Opioid Receptor on the Analgesic Action of Intrathecal Sildenafil in Rats  

Lee, Hyung Gon (Department of Anesthesiology and Pain Medicine, Medical School, Chonnam University)
Jeong, Chang Young (Department of Anesthesiology and Pain Medicine, Medical School, Chonnam University)
Yoon, Myung Ha (Department of Anesthesiology and Pain Medicine, Medical School, Chonnam University)
Kim, Woong Mo (Department of Anesthesiology and Pain Medicine, Medical School, Chonnam University)
Shin, Seung Heon (Department of Anesthesiology and Pain Medicine, Medical School, Chonnam University)
Kim, Yeo Ok (Department of Anesthesiology and Pain Medicine, Medical School, Chonnam University)
Huang, Lan Ji (Brain Korea 21 Project, Center for Biomedical Human Resources at Chonnam University)
Cui, Jin Hua (Brain Korea 21 Project, Center for Biomedical Human Resources at Chonnam University)
Publication Information
The Korean Journal of Pain / v.20, no.1, 2007 , pp. 21-25 More about this Journal
Abstract
Background: Intrathecal sildenafil has produced antinociception by increasing the cGMP through inhibition of phosphodiesterase 5. Spinal opioid receptor has been reported to be involved in the modulation of nociceptive transmission. The aim of this study was to examine the role of opioid receptor in the effect of sildenafil on the nociception evoked by formalin injection. Methods: Rats were implanted with lumbar intrathecal catheters. Formalin testing was used as a nociceptive model. Formalin-induced nociceptive behavior (flinching response) was observed. To clarify the role of the opioid receptor for the analgesic action of sildenafil, naloxone was administered intrathecally 10 min before sildenafil delivery, and formalin was then injected 10 min later. Results: Intrathecal sildenafil produced dose-dependent suppression of flinches in both phases during the formalin test. Intrathecal naloxone reversed the analgesic effect of sildenafil in both phases. Conclusions: Sildenafil is active against the nociceptive state that's evoked by a formalin stimulus, and the opioid receptor is involved in the analgesic action of sildenafil at thespinal level.
Keywords
analgesia; cyclic guanosine monophosphate; opioid receptor; phosphodiesterase; sildenafil; Spinal code;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Asomoza-Espinosa R, Alonso-Lopez R, Mixcoatl-Zecuatl T, Aguirre-Banuelos P, Torres-Lopez JE, Granados-Soto V: Sildenafil increases diclofenac antinociception in the formalin test. Em J Pharmacol 2001; 418: 195-200   DOI   ScienceOn
2 Beavo JA, Reifsnyder DH: Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol Sci 1990; 11: 150-5   DOI   ScienceOn
3 Przesmycki K, Dzieciuch JA, Czuczwar SJ, Kleiurok Z: Isobolographic analysis of interaction between intrathecal morphine and clonidine in the formalin test in rats. Eur J Pharmacol 1997; 337: 11-7   DOI   ScienceOn
4 Pacheco DF, Reis GM, Francischi JN, Castro MS, Perez AC, Duarte ID: delta-Opioid receptor agonist SNC80 elicits peripheral antinociception via delta(1) and delta(2) receptors and activation of the l-arginine/nitric oxide/cyclic GMP pathway. Life Sci 2005; 78: 54-60   DOI   ScienceOn
5 Beavo JA: Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 1995; 75: 725-48   DOI
6 Yoon MH, Bae HB, Shin DJ, Kim CM, Jeong ST, Kim SJ, et al: Evaluation for the effects of intrathecal sildenafil on the formalin- and thermal-induced nociception of rats. Korean J Pain 2006; 19: 17-21   DOI   ScienceOn
7 Boolell M, Gepi-Attee S, Gingell JC, Allen MJ: Sildenafil, a novel effective oral therapy for male erectile dysfunction. Br J Urol 1996; 78: 257-61   DOI   ScienceOn
8 Moncada S, Higgs A: The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002-12   DOI   ScienceOn
9 Yoon MH, Choi JI, Kim SJ, Kim CM, Bae HB, Chung ST: Synergistic antinociception between zaprinast and morphine in the spinal cord of rats on the formalin test. Eur J Anaesthesiol 2006; 23: 65-70
10 Nathan C: Inducible nitric oxide synthase: what difference does it make? J Clin Invest 1997; 100: 2417-23   DOI   ScienceOn
11 Uckert S, Hedlund P, Andersson KE, Truss MC, Jonas U, Stief CG: Update on phosphodiesterase (PDE) isoenzymes as pharmacologic targets in urology: present and future. Eur Urol 2006; 50: 1194-207   DOI   ScienceOn
12 Wilcox GL, Seybold V: Pharmacology of spinal afferent processing. In: Anesthesia: biologic foundations. Edited by Yaksh TL, Lynch C III, Zapol WM, Maze M, Biebuyck JF, Saidman LJ: Philadelphia, Lippincott-Raven Publishers. 1997, pp 557-76
13 Araiza-Saldana CI, Reyes-Garcia G, Bermudez-Ocana DY, Perez-Severiano F, Granados-Soto V: Effect of diabetes on the mechanisms of intrathecal antinociception of sildenafil in rats. Eur J Pharmacol 2005; 527: 60-70   DOI   ScienceOn
14 Patil CS, Jain NK, Singh A, Kulkarni SK: Modulatory effect of cyclooxygenase inhibitors on sildenafil-induced antinociception. Pharmacology 2003; 69: 183-9   DOI   ScienceOn
15 Jain NK, Patil CS, Singh A, Kulkarni SK: Sildenafil-induced peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway. Brain Res 2001; 909: 170-8   DOI   ScienceOn
16 Jain NK, Patil CS, Singh A, Kulkarni SK: Sildenafil, a phosphodiesterase-5 inhibitor, enhances the antinociceptive effect of morphine. Pharmacology 2003; 67: 150-6   DOI   ScienceOn
17 Mixcoatl-Zecuatl T, Aguirre-Banuelos P, Granados-Soto V: Sildenafil produces antinociception and increases morphine antinociception in the formalin test. Em J Pharmacol 2000; 400: 81-7   DOI   ScienceOn
18 Pyne NJ, Arshavsky V, Lochhead A: cGMP signal termination. Biochem Soc Trans 1996; 24: 1019-22   DOI
19 Yaksh TL, Rudy TA: Chronic catheterization of the spinal subarachnoid space. Physiol Behav 1976; 17: 1031-6   DOI   ScienceOn